Abstract:Background Senile osteoporosis can cause bone fragility and increased risk for fractures and has been one of the most prevalent and severe diseases affecting the elderly population worldwidely. The underlying mechanisms are currently intensive areas of investigation. In age-related bone loss, decreased bone formation overweighs increased bone resorption. The molecular mechanisms underlying defective bone formation in age-related bone loss are not completely understood. In particular, the specific role of histone acetylation in age-related bone loss has not been examined thoroughly. Methods We employed 6- and 18-month-old mice to investigate the mechanisms of defective bone formation in age-related bone loss. Bone marrow stromal cells (BMSCs) were induced to undergo in vitro osteogenic differentiation. Chromatin immunoprecipitation (ChIP) was used to investigate the binding of histone deacetylases (HDACs) on Runx2 promoter in BMSCs. Luciferase reporter and transient transfection assay were employed to study Runx2 gene expression modulation by HDAC and androgen receptor (AR). siRNA and HDAC6 inhibitor, Tubastatin A, were used to inhibit HDAC6 in vitro. And systemic administration of Tubastatin A was used to block HDAC6 in vivo. Results Age-related trabecular bone loss was observed in 18-month-old mice compared with 6-month-old mice. In vitro osteogenic differentiation potential of BMSCs from 18-month-old mice was weaker than 6-month-old mice, in which there was Runx2 expression inactivation in BMSCs of 18-month-old mice compared with 6-month-old mice, which was attributable to HDAC6-mediated histone hypoacetylation in Runx2 promoter. There was competitive binding of HDAC6 and AR on Runx2 promoter to modulate Runx2 expression in BMSCs. More importantly, through siRNA- or specific inhibitor-mediated HDAC6 inhibition, we could activate Runx2 expression, rescue in vitro osteogenesis potential of BMSCs, and alleviate in vivo age-related bone loss of mice. Conclusion HDAC6 accumulation and histone hypoacetylation on Runx2 promoter contributed to the attenuation of in vitro osteogenic differentiation potential of BMSCs from aged mice. Through HDAC6 inhibition, we could activate Runx2 expression and osteogenic differentiation potential of BMSCs from aged mice and alleviate the age-related bone loss of aged mice. Our study will benefit not only for understanding the age-related bone loss, but also for finding new therapies to treat senile osteoporosis.

HDAC6 inactivates Runx2 promoter to block osteogenesis of bone marrow stromal cells in age-related bone loss of mice

Histone Deacetylase 8 Suppresses Osteogenic Differentiation of Bone Marrow Stromal Cells by Inhibiting Histone H3K9 Acetylation and RUNX2 Activity.

Activation of 4-1BB signaling in bone marrow stromal cells triggers bone loss via the p-38 MAPK-DKK1 axis in aged mice

Correction: Impaired Autophagy Triggered by HDAC9 in Mesenchymal Stem Cells Accelerates Bone Mass Loss

The age-related characteristics in bone microarchitecture, osteoclast distribution pattern, functional and transcriptomic alterations of BMSCs in mice

A Novel Microrna Targeting Hdac5 Regulates Osteoblast Differentiation in Mice and Contributes to Primary Osteoporosis in Humans

Histone Arginine Methylation-Mediated Epigenetic Regulation of Discoidin Domain Receptor 2 Controls the Senescence of Human Bone Marrow Mesenchymal Stem Cells.

Hypoxia-inducible factor-2α mediates senescence-associated intrinsic mechanisms of age-related bone loss

Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells.

MicroRNA-188 Regulates Age-Related Switch Between Osteoblast and Adipocyte Differentiation.

Mechanical Stimulation Orchestrates the Osteogenic Differentiation of Human Bone Marrow Stromal Cells by Regulating HDAC1

Histone Deacetylase 6 Promotes Skin Wound Healing by Regulating Fibroblast Migration and Differentiation in Aged Mice.

Dynamic and Distinct Histone Modifications of Osteogenic Genes During Osteogenic Differentiation

Single-cell Multi-Omics Identify Novel Regulators Required for Osteoclastogenesis During Ageing

Hedgehog Signaling Controls Bone Homeostasis by Regulating Osteogenic/Adipogenic Fate of Skeletal Stem/Progenitor Cells in Mice

Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells.

DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age

Hypermethylation of Bmp2 and Fgfr2 Promoter Regions in Bone Marrow Mesenchymal Stem Cells Leads to Bone Loss in Prematurely Aged Mice.

Analysis of Hdac1-Mediated Regulation of Runx2-Induced Osteopontin Gene Expression in C3h10t1/2 Cells

The chromatin remodeling factor Arid1a cooperates with Jun/Fos to promote osteoclastogenesis by epigenetically upregulating Siglec15 expression

FOXO1 differentially regulates bone formation in young and aged mice